Recombinant Human CEACAM-5/CD66e (501-685) Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00173P-100UG
Human CEACAM-5 (501-685) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human CEACAM-5/CD66e (501-685) Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00173P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human CEACAM-5/CD66e (501-685) Protein is expressed from HEK293 with His tag at the C-terminus.It contains Pro501-Ala685. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | P06731 |
Target Symbol | CEACAM-5/CD66e (501-685) |
Species | Human |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Pro501-Ala685 |
Mol. Weight | The protein has a predicted MW of 20.89 kDa. Due to glycosylation, the protein migrates to 50-70 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Human CEACAM-5, His Tag at 2ug/ml (100ul/well) on the plate. Dose response curve for Anti-CEACAM5 Antibody, hFc Tag with the EC50 of 28.8ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) was identified as a metastatic driver. CEACAM5 overproduction enriched for an epithelial gene expression pattern and facilitated tumor outgrowth at metastatic sites. Tissues from patients with metastatic breast cancer confirmed elevated levels of CEACAM5 in lung metastases relative to breast tumors, and an inverse correlation between CEACAM5 and the mesenchymal marker vimentin was demonstrated. |